Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis

Overview of attention for article published in Frontiers in immunology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 53,309 followers.

Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis: Introduction This meta-analysis aims to evaluate the efficacy and safety of… … #immunology https://t.co/4uxbM

10 Jan 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer:…

10 Jan 2024

Reply Repost Favourite

New Research: Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis: Introduction This meta-analysis aims to evaluate the efficacy and safety of… https://t.co/aYiMA

09 Jan 2024

Reply Repost Favourite

https://t.co/23EWtGIUtI

09 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.